The cytokeratin-18 fragment, which is a molecule cleaved by caspase and released from apoptotic hepatocytes, is used as one of the diagnostic biomarkers in NASH patients28,29. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatohepatitis.